{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:50:45Z","timestamp":1740135045793,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC82073345"],"award-info":[{"award-number":["NSFC82073345"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Innovation and Development Joint Foundation of Shandong Province","award":["ZR202209010002"],"award-info":[{"award-number":["ZR202209010002"]}]},{"name":"Jinan Clinical Medicine Science and Technology Innovation Plan","award":["202019060"],"award-info":[{"award-number":["202019060"]}]},{"name":"Taishan Scholars Program to Shuanghu Yuan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13135-3","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T12:24:49Z","timestamp":1731068689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determining optimal clinical target volume margins based on microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer after chemotherapy or chemotherapy combined with immunotherapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Yujiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaran","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuanghu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"key":"13135_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"13135_CR2","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1002\/onco.13590","volume":"26","author":"EL Schenk","year":"2021","unstructured":"Schenk EL, Patil T, Pacheco J, Bunn PA. 2020 Innovation-based optimism for Lung Cancer outcomes. Oncologist. 2021;26:e454\u201372.","journal-title":"Oncologist"},{"key":"13135_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3322\/caac.21689","volume":"71","author":"K Wang","year":"2021","unstructured":"Wang K, Tepper JE. Radiation therapy-associated toxicity: etiology, management, and prevention. CA Cancer J Clin. 2021;71:437\u201354.","journal-title":"CA Cancer J Clin"},{"key":"13135_CR4","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0360-3016(00)00750-1","volume":"48","author":"P Giraud","year":"2000","unstructured":"Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De Rycke Y, et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys. 2000;48:1015\u201324.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13135_CR5","first-page":"11268","volume":"8","author":"W Liu","year":"2015","unstructured":"Liu W, Shao Y, Guan B, Hao J, Cheng X, Ji K, et al. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection. Int J Clin Exp Pathol. 2015;8:11268\u201377.","journal-title":"Int J Clin Exp Pathol"},{"key":"13135_CR6","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00428-018-2309-1","volume":"472","author":"C Luchini","year":"2018","unstructured":"Luchini C, Veronese N, Nottegar A, Cheng M, Kaneko T, Pilati C, et al. Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis. Virchows Arch. 2018;472:939\u201347.","journal-title":"Virchows Arch"},{"key":"13135_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1378\/chest.06-1810","volume":"131","author":"YC Lee","year":"2007","unstructured":"Lee YC, Wu CT, Kuo SW, Tseng YT, Chang YL. Significance of extranodal extension of regional lymph nodes in surgically resected non-small cell lung cancer. Chest. 2007;131:993\u20139.","journal-title":"Chest"},{"key":"13135_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jtho.2023.08.003","volume":"19","author":"H Xie","year":"2024","unstructured":"Xie H, Dai C, Gu C, Zhao S, Xu L, Wang F, et al. Validation of the Proposed International Association for the study of Lung Cancer residual tumor classification to Upgrade Extracapsular Extension of Tumor in Nodes from R0 to Incomplete Resection. J Thorac Oncol. 2024;19:130\u201340.","journal-title":"J Thorac Oncol"},{"key":"13135_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.ijrobp.2006.08.057","volume":"67","author":"S Yuan","year":"2007","unstructured":"Yuan S, Meng X, Yu J, Mu D, Chao KS, Zhang J, et al. Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;67:727\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13135_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1056\/NEJM199401203300301","volume":"330","author":"R Rosell","year":"1994","unstructured":"Rosell R, G\u00f3mez-Codina J, Camps C, Maestre J, Padille J, Cant\u00f3 A, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med. 1994;330:153\u20138.","journal-title":"N Engl J Med"},{"key":"13135_CR11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/jnci\/86.9.673","volume":"86","author":"JA Roth","year":"1994","unstructured":"Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr., Lee JS, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst. 1994;86:673\u201380.","journal-title":"J Natl Cancer Inst"},{"key":"13135_CR12","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1200\/JCO.2009.26.1685","volume":"28","author":"KM Pisters","year":"2010","unstructured":"Pisters KM, Valli\u00e8res E, Crowley JJ, Franklin WA, Bunn PA Jr., Ginsberg RJ, et al. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. J Clin Oncol. 2010;28:1843\u20139.","journal-title":"J Clin Oncol"},{"key":"13135_CR13","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1200\/JCO.2009.27.6204","volume":"28","author":"E Felip","year":"2010","unstructured":"Felip E, Rosell R, Maestre JA, Rodr\u00edguez-Paniagua JM, Mor\u00e1n T, Astudillo J, et al. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. J Clin Oncol. 2010;28:3138\u201345.","journal-title":"J Clin Oncol"},{"key":"13135_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1200\/JCO.2010.33.7089","volume":"30","author":"GV Scagliotti","year":"2012","unstructured":"Scagliotti GV, Pastorino U, Vansteenkiste JF, Spaggiari L, Facciolo F, Orlowski TM, et al. Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer. J Clin Oncol. 2012;30:172\u20138.","journal-title":"J Clin Oncol"},{"key":"13135_CR15","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","volume":"386","author":"PM Forde","year":"2022","unstructured":"Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, et al. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. N Engl J Med. 2022;386:1973\u201385.","journal-title":"N Engl J Med"},{"key":"13135_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJMoa2302983","volume":"389","author":"H Wakelee","year":"2023","unstructured":"Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S, et al. Perioperative Pembrolizumab for Early-Stage Non-small-cell Lung Cancer. N Engl J Med. 2023;389:491\u2013503.","journal-title":"N Engl J Med"},{"key":"13135_CR17","doi-asserted-by":"crossref","unstructured":"Cascone T, Awad MM, Spicer J, He J, Lu S, Sepesi B et al. LBA1 CheckMate 77T: phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II\u2013IIIb NSCLC. Annals of Oncology. 2023.","DOI":"10.1016\/j.annonc.2023.10.050"},{"key":"13135_CR18","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/jnci\/88.17.1210","volume":"88","author":"RO Dillman","year":"1996","unstructured":"Dillman RO, Herndon J, Seagren SL, Eaton WL Jr., Green MR. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst. 1996;88:1210\u20135.","journal-title":"J Natl Cancer Inst"},{"key":"13135_CR19","doi-asserted-by":"crossref","unstructured":"Sause W, Kolesar P, Taylor SI, Johnson D, Livingston R, Komaki R et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest. 2000; 117:358\u2013364.","DOI":"10.1378\/chest.117.2.358"},{"key":"13135_CR20","doi-asserted-by":"publisher","first-page":"e16350","DOI":"10.1200\/JCO.2024.42.16_suppl.e16350","volume":"42","author":"X Guo","year":"2024","unstructured":"Guo X, Zhou Y, Ji Y, Lou W, Wu L, Wang W. TisCRT-LAPC: a phase II study of tislelizumab combined with nab-paclitaxel and gemcitabine (AG) followed by consolidative radiotherapy in locally advanced pancreatic cancer (LAPC). J Clin Oncol. 2024;42:e16350\u201316350.","journal-title":"J Clin Oncol"},{"key":"13135_CR21","doi-asserted-by":"publisher","first-page":"102795","DOI":"10.1016\/j.eclinm.2024.102795","volume":"75","author":"D Chen","year":"2024","unstructured":"Chen D, Zou B, Li B, Gao A, Huang W, Shao Q, et al. Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC): a phase II trial. EClinicalMedicine. 2024;75:102795.","journal-title":"EClinicalMedicine"},{"key":"13135_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cllc.2024.06.007","volume":"25","author":"M Reck","year":"2024","unstructured":"Reck M, Nadal E, Girard N, Filippi AR, Martin LW, Gay CM, et al. MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy followed by either surgery and adjuvant durvalumab or chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable stage IIB-IIIB NSCLC. Clin Lung Cancer. 2024;25:587\u2013e593583.","journal-title":"Clin Lung Cancer"},{"key":"13135_CR23","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ijrobp.2005.08.020","volume":"64","author":"S Apisarnthanarax","year":"2006","unstructured":"Apisarnthanarax S, Elliott DD, El-Naggar AK, Asper JA, Blanco A, Ang KK, et al. Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes. Int J Radiat Oncol Biol Phys. 2006;64:678\u201383.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13135_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4149\/neo_2014_042","volume":"61","author":"ZW Wang","year":"2014","unstructured":"Wang ZW, Zhang W, Dong W, Li BS, Mu DB, Huang W, et al. Pathological analysis of extracapsular extension of metastatic lymph node and its potential impact on nodal clinical target volume in the radiotherapy of esophageal squamous cell carcinoma. Neoplasma. 2014;61:324\u201330.","journal-title":"Neoplasma"},{"key":"13135_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12916-021-02143-w","volume":"19","author":"S Nie","year":"2021","unstructured":"Nie S, Zhu Y, Yang J, Xin T, Xue S, Sun J, et al. Clinicopathologic analysis of microscopic tumor extension in glioma for external beam radiotherapy planning. BMC Med. 2021;19:269.","journal-title":"BMC Med"},{"key":"13135_CR26","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/cncr.32586","volume":"126","author":"X Hu","year":"2020","unstructured":"Hu X, Bao Y, Xu YJ, Zhu HN, Liu JS, Zhang L, et al. Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses. Cancer. 2020;126:840\u20139.","journal-title":"Cancer"},{"key":"13135_CR27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.prro.2021.05.006","volume":"11","author":"C Meynard","year":"2021","unstructured":"Meynard C, Mansuet-Lupo A, Giraud N, Boulle G, Imbault P, Gu\u00e9n\u00e9gou-Arnoux A, et al. Size and predictive factors of microscopic tumor extension in locally Advanced Non-small Cell Lung Cancer. Pract Radiat Oncol. 2021;11:491\u2013501.","journal-title":"Pract Radiat Oncol"},{"key":"13135_CR28","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.ijrobp.2009.03.065","volume":"76","author":"P Ghadjar","year":"2010","unstructured":"Ghadjar P, Schreiber-Facklam H, Gr\u00e4ter R, Evers C, Simcock M, Geretschl\u00e4ger A, et al. Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2010;76:1127\u201332.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13135_CR29","doi-asserted-by":"crossref","unstructured":"Schmitt M, Aussenac L, Seitlinger J, Lindner V, No\u00ebl G, Antoni D. Evaluation of microscopic Tumour Extension in Localized Stage Non-small-cell Lung Cancer for Stereotactic Radiotherapy Planning. Cancers (Basel). 2022;14:1282.","DOI":"10.3390\/cancers14051282"},{"key":"13135_CR30","first-page":"566","volume":"25","author":"WL Li","year":"2003","unstructured":"Li WL, Yu JM, Liu GH, Zhong WX, Li WW, Zhang BJ. [A comparative study on radiology and pathology target volume in non-small-cell lung cancer]. Zhonghua Zhong Liu Za Zhi. 2003;25:566\u20138.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"13135_CR31","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/1097-0142(19850901)56:5<979::AID-CNCR2820560502>3.0.CO;2-N","volume":"56","author":"R Holland","year":"1985","unstructured":"Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979\u201390.","journal-title":"Cancer"},{"key":"13135_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1006\/gyno.1998.5271","volume":"73","author":"MS Hoffman","year":"1999","unstructured":"Hoffman MS, Gunesakaran S, Arango H, DeCesare S, Fiorica JV, Parsons M, et al. Lateral microscopic extension of squamous cell carcinoma of the vulva. Gynecol Oncol. 1999;73:72\u20135.","journal-title":"Gynecol Oncol"},{"key":"13135_CR33","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1111\/1759-7714.14000","volume":"12","author":"L Gao","year":"2021","unstructured":"Gao L, Wang X, Yang X, Gu R, Zhu G, Gao X. A clinicopathologic analysis of microscopic extension in small cell lung cancer and lung adenocarcinoma: determination of clinical target volume with precise radiotherapy. Thorac Cancer. 2021;12:1973\u201382.","journal-title":"Thorac Cancer"},{"key":"13135_CR34","first-page":"100225","volume":"2","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Zhang L, Hu J, Wang D, Hu C, Zhou J, et al. Pembrolizumab Plus Chemotherapy for Chinese patients with metastatic squamous NSCLC in KEYNOTE-407. JTO Clin Res Rep. 2021;2:100225.","journal-title":"JTO Clin Res Rep"},{"key":"13135_CR35","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1200\/JCO.19.03136","volume":"38","author":"S Gadgeel","year":"2020","unstructured":"Gadgeel S, Rodr\u00edguez-Abreu D, Speranza G, Esteban E, Felip E, D\u00f3mine M, et al. Updated analysis from KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for previously untreated metastatic nonsquamous non-small-cell Lung Cancer. J Clin Oncol. 2020;38:1505\u201317.","journal-title":"J Clin Oncol"},{"key":"13135_CR36","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jtho.2021.05.005","volume":"16","author":"S Lu","year":"2021","unstructured":"Lu S, Wang J, Yu Y, Yu X, Hu Y, Ai X, et al. Tislelizumab Plus Chemotherapy as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC (RATIONALE 304): a randomized phase 3 trial. J Thorac Oncol. 2021;16:1512\u201322.","journal-title":"J Thorac Oncol"},{"key":"13135_CR37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/jamaoncol.2021.0366","volume":"7","author":"J Wang","year":"2021","unstructured":"Wang J, Lu S, Yu X, Hu Y, Sun Y, Wang Z, et al. Tislelizumab Plus Chemotherapy vs Chemotherapy alone as first-line treatment for Advanced squamous non-small-cell Lung Cancer: a phase 3 Randomized Clinical Trial. JAMA Oncol. 2021;7:709\u201317.","journal-title":"JAMA Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13135-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13135-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13135-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T13:04:43Z","timestamp":1731071083000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13135-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["13135"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13135-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Review Board of Shandong Cancer Hospital and Institute (ethics approval number: No. SDTHEC2022009020). Informed consent has been obtained from the patients. The study was carried out in accordance with the World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors of the current manuscript meet the specified criteria for authorship and agreed to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1368"}}